5JK3
Crystal structure of TL11-128 bound to TAK1-TAB1
Summary for 5JK3
Entry DOI | 10.2210/pdb5jk3/pdb |
Descriptor | Mitogen-activated protein kinase kinase kinase 7,TGF-beta-activated kinase 1 and MAP3K7-binding protein 1, ~{N}-[2-[5-chloranyl-2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]oxyphenyl]prop-2-enamide (2 entities in total) |
Functional Keywords | mitogen activated protein kinase kinase kinase 7, tgf-beta activated kinase 1 and map3k7-binding protein 1 chimera, serine/threonine kinase which act as essential component of the map kinase signal transduction pathway, transferase-transferase inhibitor complex, transferase/transferase inhibitor |
Biological source | Homo sapiens (Human) More |
Total number of polymer chains | 1 |
Total formula weight | 35834.66 |
Authors | Gurbani, D.,Westover, K.D. (deposition date: 2016-04-25, release date: 2017-02-15, Last modification date: 2024-10-16) |
Primary citation | Tan, L.,Gurbani, D.,Weisberg, E.L.,Hunter, J.C.,Li, L.,Jones, D.S.,Ficarro, S.B.,Mowafy, S.,Tam, C.P.,Rao, S.,Du, G.,Griffin, J.D.,Sorger, P.K.,Marto, J.A.,Westover, K.D.,Gray, N.S. Structure-guided development of covalent TAK1 inhibitors. Bioorg. Med. Chem., 25:838-846, 2017 Cited by PubMed: 28011204DOI: 10.1016/j.bmc.2016.11.035 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.371 Å) |
Structure validation
Download full validation report